1. Home
  2. ELVN vs LZ Comparison

ELVN vs LZ Comparison

Compare ELVN & LZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • LZ
  • Stock Information
  • Founded
  • ELVN 2016
  • LZ 2001
  • Country
  • ELVN United States
  • LZ United States
  • Employees
  • ELVN N/A
  • LZ N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • LZ EDP Services
  • Sector
  • ELVN Health Care
  • LZ Technology
  • Exchange
  • ELVN Nasdaq
  • LZ Nasdaq
  • Market Cap
  • ELVN 1.1B
  • LZ 1.4B
  • IPO Year
  • ELVN 2020
  • LZ 2021
  • Fundamental
  • Price
  • ELVN $23.56
  • LZ $7.56
  • Analyst Decision
  • ELVN Strong Buy
  • LZ Hold
  • Analyst Count
  • ELVN 5
  • LZ 9
  • Target Price
  • ELVN $37.80
  • LZ $7.92
  • AVG Volume (30 Days)
  • ELVN 191.8K
  • LZ 1.2M
  • Earning Date
  • ELVN 11-13-2024
  • LZ 02-20-2025
  • Dividend Yield
  • ELVN N/A
  • LZ N/A
  • EPS Growth
  • ELVN N/A
  • LZ 212.91
  • EPS
  • ELVN N/A
  • LZ 0.13
  • Revenue
  • ELVN N/A
  • LZ $678,838,000.00
  • Revenue This Year
  • ELVN N/A
  • LZ $6.16
  • Revenue Next Year
  • ELVN N/A
  • LZ $2.28
  • P/E Ratio
  • ELVN N/A
  • LZ $57.52
  • Revenue Growth
  • ELVN N/A
  • LZ 4.65
  • 52 Week Low
  • ELVN $10.90
  • LZ $5.33
  • 52 Week High
  • ELVN $30.03
  • LZ $13.74
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 44.52
  • LZ 43.51
  • Support Level
  • ELVN $21.55
  • LZ $7.46
  • Resistance Level
  • ELVN $24.32
  • LZ $7.96
  • Average True Range (ATR)
  • ELVN 1.43
  • LZ 0.26
  • MACD
  • ELVN 0.05
  • LZ -0.07
  • Stochastic Oscillator
  • ELVN 47.24
  • LZ 16.67

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About LZ LegalZoom.com Inc.

LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.

Share on Social Networks: